Humana Inc (HUM)
Official siteHEALTHCARE • HEALTHCARE PLANS • NYSE
Market Cap: $55.40B
Last updated: Nov 17, 2026 at 4:44 PM ET
Humana Inc (HUM) Stock Chart
Humana (HUM) has a latest price of $443.43 on Nov 17, 2026, 4.2% below its 52-week high of $462.87. Its price rose 89.1% over the past 12 months. The month-end price rose 141.6% over the 10 years through Oct 2026, a compound annual rate of 9.2%.
Price Chart
From Oct 2016 to Oct 2026, its highest month-end close was $558.08 in Oct 2022 and its lowest $171.53 in Oct 2016, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart HUM with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for HUM.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price rose 17.6%, and over 6 months it rose 43.1%. The month-end price fell 20.9% over the 3 years through Oct 2026, a compound annual decline of 7.5%.
| Period | Change |
|---|---|
| 1 month | +7.1% |
| 3 months | +17.6% |
| 6 months | +43.1% |
| 12 months | +89.1% |
| 12 months, with dividends | +90.6% |
| Period | Change | Per year |
|---|---|---|
| 3 years | -20.9% | -7.5% |
| 5 years | -10.5% | -2.2% |
| 10 years | +141.6% | +9.2% |
Price by Year
Its best calendar year was 2019, when the price rose 27.9%, and its weakest was 2024, when it fell 44.6%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $414.50 | +61.8% |
| 2025 | $256.13 | +1.0% |
| 2024 | $253.71 | -44.6% |
| 2023 | $457.81 | -10.6% |
| 2022 | $512.19 | +10.4% |
| 2021 | $463.86 | +13.1% |
| 2020 | $410.27 | +11.9% |
| 2019 | $366.52 | +27.9% |
| 2018 | $286.48 | +15.5% |
| 2017 | $248.07 | +21.6% |
Trading Range
The price is 8.1% above its 50-day average of $410.04 and 39.0% above its 200-day average of $319.10.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $443.43 | |
| 52-week high | $462.87 | -4.2% |
| 52-week low | $161.56 | +174.5% |
| 50-day average | $410.04 | +8.1% |
| 200-day average | $319.10 | +39.0% |
Price Risk
Over 3 years, its largest fall from a peak was 67.6%.
| Measure | Value |
|---|---|
| 1-year beta | 0.54 |
| Largest fall, 1 year | -42.4% |
| Largest fall, 3 years | -67.6% |
Valuation
Humana traded at 15.0x earnings at the end of 2025, against a 5-year median of 17.4x and a 10-year median of 19.7x.
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About HUM
What is HUM's 1-year price change?
Humana's price rose 89.1% over the past 12 months. With dividends included, the 12-month total return was 90.6%.
What is HUM's 5-year price change?
Humana's month-end price fell 10.5% over the 5 years through Oct 2026, a compound annual decline of 2.2%. These figures leave out dividends.
What is HUM's 52-week high and low?
Humana's 52-week high is $462.87 and its 52-week low is $161.56. Its latest price of $443.43 on Nov 17, 2026 is 4.2% below the high.
What is HUM's beta?
Humana's 1-year beta against the S&P 500 is 0.54, so its price has moved less than the market over the past year. Its largest fall from a peak over the past year was 42.4%.
Is the HUM chart free?
Yes. Advanced Charting for HUM is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
HUM pages: Overview, Dividends, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors